PuSH - Publication Server of Helmholtz Zentrum München: The impact of antithymocyte globulin on short-term toxicity after allogenic stem cell transplantation.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Pihusch, R.* ; Holler, E.* ; Mühlbayer, D.* ; Göhring, P.* ; Stötzer, O.* ; Hiller, E.* ; Kolb, H.-J.

The impact of antithymocyte globulin on short-term toxicity after allogenic stem cell transplantation.

Bone Marrow Transplant. 30, 347-354 (2002)

DOI

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Antithymocyte globulin (ATG) is commonly used in allogeneic haematopoietic stem cell transplantation (HSCT). Little information is available, however, as to the optimal protocol for use and the side-effects occurring if ATG is administered in high daily doses (10-30 mg/kg). We report our experience with ATG Fresenius (ATG-F) in conditioning for allogeneic HSCT. During a period of 3 days, 47 patients received doses between 10 and 30 mg/kg either over 4 h preceded by 1-1.5 mg/kg prednisolone 30 min before the start of ATG-F (protocol A) or alternatively, over 12 h with 3-4 mg/kg prednisolone being administered before and 6 h after start of ATG (protocol B). During treatment with ATG-F, the side-effects observed included inflammation, disseminated intravascular coagulation, hyperdynamic circulation and renal dysfunction. Although these complications caused substantial morbidity, they were reversible within a few days. Side-effects were significantly more severe in patients treated according to protocol A than in those treated according to protocol B. As prolonged infusion of ATG-F does not reduce T cell clearance due to the long half-life of ATG-F, and since less cytokine release during conditioning might have beneficial long-term effects, we recommend administering ATG-F over 12 h preceded by high-dose steroid treatment.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords antithymocyte globulin; side-effects; treatment; transplantation

ISSN (print) / ISBN 0268-3369

e-ISSN 1476-5365

Journal Bone Marrow Transplantation

Quellenangaben Volume: 30, Issue: 6, Pages: 347-354

Publisher Nature Publishing Group

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) CCG Hematopoetic Cell Transplants (IMI-KHZ)